Glad to see you here also BL. I enjoy reading your thoughtful input. Your ihub post may very well be the case where a deal isn’t possible for HIV/GvHD at this point due to the numbers being so far apart.

I hope the NSTG SA article has substance and extend the clock for a better deal with leronlimab. I’m sure the BOD fully understands that giving up a little with the prognostic test will result in more with leronlimab.